Publication:
The global threat of counterfeit drugs: Why industry and governments must communicate the dangers

Simple item page
dc.contributor.authorRobert Cockburnen_US
dc.contributor.authorPaul N. Newtonen_US
dc.contributor.authorE. Kyeremateng Agyarkoen_US
dc.contributor.authorDora Akunyilien_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherFood and Drugs Board Ghanaen_US
dc.contributor.otherNational Agency for Food and Drug Administration and Control, Abujaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-06-21T08:26:50Z
dc.date.available2018-06-21T08:26:50Z
dc.date.issued2005-06-06en_US
dc.identifier.citationPLoS Medicine. Vol.2, (2005), 0302-0308en_US
dc.identifier.doi10.1371/journal.pmed.0020100en_US
dc.identifier.issn15491277en_US
dc.identifier.other2-s2.0-19344368212en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/16951
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=19344368212&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe global threat of counterfeit drugs: Why industry and governments must communicate the dangersen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=19344368212&origin=inwarden_US

Files

Collections

Scopus 2001-2005